GleamWall
中文EN

AORT ARTIVION, INC.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 784199 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.0%
TTM net income YoY-92.5%
TTM EPS YoY-56.5%
Revenue 3-yr CAGR12.4%
Net income 3-yr CAGR—

Margins

Gross margin63.3%
Operating margin2.3%
Net margin-3.7%
FCF margin-9.2%
EBITDA margin7.7%

Returns

ROE-4.0%
ROA-1.9%
ROIC (approx.)1.3%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets57.2%
Debt / equity0.81x
Current ratio4.42x
Interest coverage0.41x

Cash quality & payout

Operating cash flow / net income-0.85x
Accruals ratio-3.4%
Payout ratio—
Capex / revenue12.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$123.79M$125.76M$116.34M$115.99M$113.39M$112.97M$98.98M$97.31M
Cost of revenue$47.81M$45.24M$40.89M$42.85M$38.99M$39.86M$35.40M$35.81M
Gross profit$75.98M$80.52M$75.45M$73.14M$74.39M$73.11M$63.58M$61.50M
R&D expense$9.81M$9.05M$8.84M$9.12M$8.08M$7.06M$6.73M$7.40M
SG&A expense$63.22M$79.83M$60.82M$56.84M$57.28M$57.66M$54.70M$51.43M
Operating income$2.95M-$8.36M$5.79M$10.68M$12.54M$8.38M$2.15M$2.67M
Interest expense$8.52M$7.25M$5.37M$5.53M$6.12M$7.27M$7.66M$9.74M
Pretax income-$5.92M-$11.70M$339,000$6.54M$7.06M$3.48M-$2.29M-$16.60M
Income tax$2.01M$1.81M-$1.08M$4.11M$554,000$2.14M-$1.79M-$119,000
Net income-$7.93M-$13.51M$1.42M$2.43M$6.50M$1.34M-$505,000-$16.48M
EBITDA$10.29M-$1.62M$12.13M$16.44M$18.25M$13.92M$7.59M$8.96M
EPS (basic)-0.16-0.280.03—0.140.03-0.01—
EPS (diluted)-0.16-0.280.03—0.130.03-0.01—
Weighted avg. shares (diluted)48.72M48.54M49.73M—48.77M45.38M42.23M—
Balance sheet
Cash & equivalents$48.40M$77.32M$55.76M$64.91M$73.43M$53.48M$37.69M$53.46M
Receivables$94.91M$97.93M$91.87M$89.76M$88.11M$91.44M$87.80M$79.46M
Inventory$107.05M$103.36M$98.00M$92.43M$90.55M$86.72M$81.93M$79.77M
Current assets$338.81M$371.38M$357.52M$358.08M$337.50M$318.82M$287.30M$290.08M
PP&E, net$81.73M$73.70M$67.74M$64.99M$40.71M$40.09M$37.81M$36.40M
Goodwill$344.96M$349.86M$251.66M$254.09M$254.00M$253.80M$245.07M$240.96M
Intangibles$145.90M$149.27M$120.00M$123.66M$126.49M$129.26M$127.53M$128.05M
Total assets$1.04B$1.07B$883.16M$884.80M$857.66M$838.39M$791.16M$789.10M
Current liabilities$76.66M$106.93M$92.70M$101.56M$85.84M$66.67M$51.94M$66.82M
Short-term debt$0$0$0$0$0$73,000$135,000$195,000
Long-term debt$363.79M$363.42M$215.35M$215.11M$214.87M$215.54M$314.61M$314.15M
Total debt$363.79M$363.42M$215.35M$215.11M$214.87M$215.61M$314.75M$314.35M
Total liabilities$595.69M$626.35M$432.69M$436.56M$418.97M$418.49M$496.91M$512.90M
Shareholders' equity$446.40M$445.58M$450.47M$448.23M$438.69M$419.90M$294.25M$276.20M
Net debt$315.39M$286.11M$159.59M$150.21M$141.44M$162.13M$277.05M$260.88M
Cash flow statement
Operating cash flow-$4.56M-$1.27M$1.15M$19.56M$22.26M$15.01M-$16.95M$10.14M
Capital expenditure$13.01M$10.75M$8.00M$27.51M$4.61M$3.29M$3.64M$1.43M
Free cash flow-$17.57M-$12.01M-$6.85M-$7.95M$17.65M$11.72M-$20.59M$8.71M
Investing cash flow-$13.01M-$129.41M-$10.50M-$30.51M-$4.61M-$3.29M-$3.64M-$11.43M
Financing cash flow-$11.28M$152.39M$463,000$2.43M$2.32M$2.60M$3.94M$174,000
Depreciation & amortization$7.34M$6.75M$6.34M$5.76M$5.72M$5.54M$5.45M$6.29M
Stock-based compensation$6.22M$8.16M$8.41M$4.08M$6.13M$6.12M$8.04M$2.74M

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.